APA

Fukudo S., Miwa H., Nakajima A., Kinoshita Y., Kosako M., Hayashi K., Akiho H., Kuroishi K., Johnston J. M., Currie M. & Ohkusa T. (20200120). High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan. : Neurogastroenterology and motility.

Chicago

Fukudo Shin, Miwa Hiroto, Nakajima Atsushi, Kinoshita Yoshikazu, Kosako Masanori, Hayashi Kenta, Akiho Hiraku, Kuroishi Kentaro, Johnston Jeffrey M, Currie Mark and Ohkusa Toshifumi. 20200120. High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan. : Neurogastroenterology and motility.

Harvard

Fukudo S., Miwa H., Nakajima A., Kinoshita Y., Kosako M., Hayashi K., Akiho H., Kuroishi K., Johnston J. M., Currie M. and Ohkusa T. (20200120). High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan. : Neurogastroenterology and motility.

MLA

Fukudo Shin, Miwa Hiroto, Nakajima Atsushi, Kinoshita Yoshikazu, Kosako Masanori, Hayashi Kenta, Akiho Hiraku, Kuroishi Kentaro, Johnston Jeffrey M, Currie Mark and Ohkusa Toshifumi. High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan. : Neurogastroenterology and motility. 20200120.